UK-based drug manufacturer GlaxoSmithKline (GSK) has received offers from local and international investors to buy its Europharm factory in Brasov, Romania.
The Brasov facility, which employs about 250 people, is engaged in the manufacturing of drugs for HIV/AIDS treatments, respiratory diseases, depression, cold and flu.
In June, the drugmaker said it was looking for a buyer for the facility in Brasov. GSK said if one could not be found, it would close it. The decision came following a wave of expired patents which led to an excess of capacity for solid oral drugs. Read more
